Literature DB >> 1349803

Expression of a human multidrug resistance gene in human ovarian carcinoma cell lines.

S Sekiya1, T Nunoyama, H Shirasawa, H Kimura, M Kawata, N Iijima, Y Sugimoto, T Tsuruo, H Takamizawa.   

Abstract

To investigate the possible role of the multidrug resistance phenotype to chemoresistance in human ovarian carcinoma, we have analyzed human multidrug resistance gene (mdr 1) expression in 8 human ovarian adenocarcinoma cell lines. An increase in P-glycoprotein level specific to multidrug-resistant tumor cells was not apparently associated with the increase in resistance to vincristine (VCR) or doxorubicin (Adriamycin). Mdr 1 transcripts (4.5 kilobases) were observed in the RNA preparation obtained from only one cell line (SHIN-3) that showed the highest resistance to both drugs in vitro and in vivo. No cell lines showed mdr 1 DNA amplification. These results suggest that the insensitivity of human ovarian carcinoma to chemotherapy could be partly explained by the expression of mdr 1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349803     DOI: 10.1007/bf02759915

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  15 in total

1.  Production of various marker substances in human ovarian cancer cell lines of epithelial origin.

Authors:  S Sekiya; N Tanaka; H Takamizawa
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

Authors:  H Hamada; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.

Authors:  H S Chan; G Bradley; P Thorner; G Haddad; B L Gallie; V Ling
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

Review 4.  Resistance to multiple chemotherapeutic agents in human cancer cells.

Authors:  M M Gottesman; I Pastan
Journal:  Trends Pharmacol Sci       Date:  1988-02       Impact factor: 14.819

5.  Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas.

Authors:  H Shirasawa; Y Tomita; S Sekiya; H Takamizawa; B Simizu
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

Review 6.  Multidrug resistance.

Authors:  J H Gerlach; N Kartner; D R Bell; V Ling
Journal:  Cancer Surv       Date:  1986

7.  Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.

Authors:  J Bénard; J Da Silva; J R Teyssier; G Riou
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

8.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

Authors:  D R Bell; J H Gerlach; N Kartner; R N Buick; V Ling
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

9.  Detection of drug resistance in human ovarian carcinoma.

Authors:  M Volm; T Efferth; M Bak; J Mattern
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

10.  Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.

Authors:  Y Ishida; T Ohtsu; H Hamada; Y Sugimoto; K Tobinai; K Minato; T Tsuruo; M Shimoyama
Journal:  Jpn J Cancer Res       Date:  1989-10
View more
  3 in total

1.  Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.

Authors:  M Sur; L Taylor; K Cooper; R K Sur
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

Review 2.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.

Authors:  Donavon C Hiss; Gary A Gabriels; Peter I Folb
Journal:  Cancer Cell Int       Date:  2007-04-18       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.